StockNews.AI
SKIN
StockNews.AI
2 hrs

BeautyHealth Appoints Philippe Schaison, PharmaD, to Board of Directors

1. Dr. Philippe Schaison joins BeautyHealth Company Board as an expert leader. 2. He has over 20 years in beauty, biotech, and consumer health sectors. 3. Schaison's leadership is expected to enhance Hydrafacial's global reach. 4. He previously held roles at Allergan, Johnson & Johnson, and L’Oréal. 5. The appointment signals potential growth and innovation for SKIN.

5m saved
Insight
Article

FAQ

Why Bullish?

Schaison's extensive experience can drive growth, similar to past leadership changes benefiting stocks.

How important is it?

The leadership change indicates stronger strategic direction, potentially affecting long-term stock performance.

Why Long Term?

Strategic enhancements from Schaison's expertise may unfold over months or years, as seen previously in similar sectors.

Related Companies

SYNACNDJNJLORALGN
Global Aesthetics Leader Brings Deep Industry Expertise and Proven Track Record Driving Growth Across Health, Beauty, and Consumer Sectors November 03, 2025 16:05 ET  | Source: The Beauty Health Company LONG BEACH, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- The BeautyHealth Company (NASDAQ: SKIN), home to flagship brand Hydrafacial, today announced the appointment of global aesthetics leader, Philippe Schaison, PharmaD, to its Board of Directors, effective as of October 30, 2025. Dr. Schaison has spent over 20 years leading organizations across the global aesthetics, biotech, and consumer health industries. He currently serves as Chief Executive Officer and a director of Soltégo, Inc., a bio-cosmetic company. Previously, Dr. Schaison was Chief Executive Officer NA of Syneron Candela, President of Allergan Aesthetics, and held senior leadership roles at Clarins, Johnson & Johnson, and L’Oréal. Today, Dr. Schaison serves as Chairman of the Board of Raziel Therapeutics Ltd., an Israeli-based biotechnology company, and sits on a number of other biomedical company boards including AIVITA Biomedical, Inc., Dyve Biosciences, Inc., and miraDry, Inc. Dr. Schaison earned an M.B.A. from Hautes Etudes Commerciales in Paris, and a Doctorate in Pharmacy from the Université Paris V René Descartes. BeautyHealth Executive Chairman Brent Saunders said: “Philippe’s experience scaling global beauty and aesthetics businesses, coupled with his proven ability to drive innovation and profitability, will bring invaluable perspective to the BeautyHealth Board. His deep expertise will help the Company unlock the full potential of the dynamic Hydrafacial brand, elevate our global reach, and accelerate category growth.” Dr. Schaison fills an open seat on the BeautyHealth Board and will join the Compensation and Nominating & Corporate Governance Committees. Following the appointment, BeautyHealth’s Board will be comprised of eight directors. About The Beauty Health CompanyThe Beauty Health Company (NASDAQ: SKIN) is a medtech meets beauty company delivering millions of skin health experiences every year that help consumers reinvent their relationship with their skin, bodies, and self-confidence. Our brands are pioneers: Hydrafacial™ in hydradermabrasion, SkinStylus™ in microneedling, and Keravive™ in scalp health. Together, with our powerful global community of estheticians, partners, and consumers, we are personalizing skin health for all ages, genders, skin tones, and skin types. We are committed to being ever more mindful in how we conduct our business to positively impact our communities and the planet. Find a local provider at https://hydrafacial.com/find-a-provider/ and learn more at beautyhealth.com or LinkedIn. Contacts: Investors: IR@beautyhealth.com Media: press@beautyhealth.com Source: BeautyHealth A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/5e88819a-f590-4e51-a7fe-66872a55b5ef Philippe Schaison Phillipe Schaison, PharmaD, to has been appointed to serve on The BeautyHealth Company Board of Dire... investors.beautyhealth.com

Related News